With regard to acquired resistance, it is informative that CRISPR screens of tumor cells evading either PD1 blockade or T cell co-culture converge on inactivation of two pathways: interferon-gamma signaling and MHC-I antigen presentation32–34. This evidence concerns the gene IFNG and neoplasm.